Neuropsychological functioning in children with early-treated phenylketonuria: impact of white matter abnormalities

Peter J Anderson1, Stephen J Wood, Dorothy E Francis

  • 1Department of Psychology, Royal Children's Hospital, Melbourne, Victoria, Australia. anderson@cryptic.rch.unimelb.edu.au

Insights

White matter abnormalities (WMAs) significantly impact cognitive function in children with early-treated phenylketonuria (ETPKU), especially when WMAs affect frontal regions. Neuropsychological deficits in ETPKU are complex, influenced by both brain structure and metabolic factors.

Area of Science:

  • Neuroscience
  • Pediatrics
  • Metabolic Disorders

Background:

  • Phenylketonuria (PKU) is a genetic disorder requiring early treatment to prevent severe intellectual disability.
  • White matter abnormalities (WMAs) are common in treated PKU, but their specific impact on cognitive function requires further elucidation.
  • Understanding the relationship between WMAs and neuropsychological outcomes is crucial for optimizing management strategies in early-treated PKU (ETPKU).

Purpose of the Study:

  • To investigate the impact of white matter abnormalities (WMAs) on neuropsychological functioning in children with early-treated phenylketonuria (ETPKU).
  • To determine the relationship between the extent and location of WMAs and specific cognitive deficits.
  • To explore the influence of phenylalanine levels on cognitive outcomes in ETPKU.

Main Methods:

  • Neuropsychological assessments were conducted on children with ETPKU and age-matched controls, evaluating attention, processing speed, memory, executive function, and academic achievement.
  • Magnetic resonance imaging (MRI) was used to identify and characterize WMAs in participants.
  • Statistical analyses examined correlations between WMA severity/location and cognitive performance, as well as associations with phenylalanine levels.

Main Results:

  • Children with ETPKU and WMAs extending into subcortical/frontal regions showed significant cognitive impairments.
  • ETPKU patients with no WMAs or only posterior periventricular WMAs exhibited milder deficits.
  • Lifetime phenylalanine levels, but not concurrent levels, correlated with deficits in several cognitive domains.

Conclusions:

  • Extensive WMAs in ETPKU are associated with compromised neural transmission and dysmyelination, leading to significant cognitive impairments.
  • Even in the absence of significant WMAs, children with ETPKU can experience cognitive problems, suggesting a multifactorial etiology.
  • Neuropsychological functioning in ETPKU is influenced by a complex interplay of biological factors (WMAs, phenylalanine levels) and environmental influences.